Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-08-10

Clinical Trial Results: OPT101 in Type 1 Diabetes Patients [Phase 1]

View source ↗

Summary

Phase 1 trial results for OPT101 in adults with Type 1 diabetes have been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OPT101

Snippet

Sponsor: Op-T LLC | Conditions: Diabetes Mellitus, Type 1 | Phase 1 | Status: COMPLETED | Results posted: 2026-08-10